Epigenetic targets in hematopoietic malignancies

Oncogene

Volumn 22, Issue 43, 2003, Pages 6489-6496

  Claus, Rainer ^a   Lübbert, Michael ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Chromatin; DNA methylation; Myelodysplastic syndromes; Myeloid leukemia

Indexed keywords

4 N ACETYLDINALINE; 4 [N (2 HYDROXYETHYL) N [2 (3 INDOLYL)ETHYL]AMINOMETHYL]CINNAMOHYDROXAMIC ACID; 5 AZA 2' DEOXYCYTIDINE; 6 (1,3 DIOXO 1H,3H BENZO[DE]ISOQUINOLIN 2 YL) N HYDROXYHEXANAMIDE; ANTINEOPLASTIC AGENT; APICIDIN; AZACITIDINE; DEPSIPEPTIDE; DEPUDECIN; DNA; DNA METHYLTRANSFERASE; FR 901228; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; N (2 AMINOPHENYL) 4 (3 PYRIDINYLMETHOXYCARBONYLAMINOMETHYL)BENZAMIDE; OXAMFLATIN; PYROXAMIDE; RETINOIC ACID; SODIUM PHENYLBUTYRATE; TRAPOXIN A; TRICHOSTATIN A; UNCLASSIFIED DRUG; VALPROIC ACID; VORINOSTAT;

ANTINEOPLASTIC ACTIVITY; BONE MARROW CELL; CANCER CHEMOTHERAPY; CHEMICAL STRUCTURE; CHROMATIN; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CLINICAL TRIAL; DNA METHYLATION; GENE SILENCING; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; LEUKEMIA; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; NEUROTOXICITY; PHASE 1 CLINICAL TRIAL; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SIDE EFFECT;

ARENA;

EID: 0242624636     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206814     Document Type: Review

References (93)

1. Aoki E, Uchida T, Ohashi H, Nagai H, Murase T, Ichikawa A, Yamao K, Hotta T, Kinoshita T, Saito H and Murate T. (2000). Leukemia, 14, 586-593.
2. Au WY, Fung A, Man C, Ma SK, Wan TS, Liang R and Kwong YL. (2003). Br. J. Haematol., 120, 1062-1065.
3. Barlow DP. (1995). Science, 270, 1610-1613.
4. Batova A, Diccianni MB, Yu JC, Nobori T, Link MP, Pullen J and Yu AL. (1997). Cancer Res., 57, 832-836.
5. Baur AS, Shaw P, Burri N, Delacretaz F, Bosman FT and Chaubert P. (1999). Blood, 94, 1773-1781.
6. Baylin SB, Hoppener JW, de Bustros A, Steenbergh PH, Lips CJ and Nelkin BD. (1986). Cancer Res., 46, 2917-2922.
7. Baylin SB, Fearon ER, Vogelstein B, de Bustros A, Sharkis SJ, Burke PJ, Staal SP and Nelkin BD. (1987). Blood, 70, 412-417.
8. Baylin SB, Herman JG, Graff JR, Vertino PM and Issa JP. (1998). Adv. Cancer Res., 72, 141-196.
9. Bird AP. (1986). Nature, 321, 209-213.
10. Bird AP and Wolffe AP. (1999). Cell, 99, 451-454.
11. Camacho L, Ryan HJ, Chanel S, Maslak P, Salomoni P, Jakubowski A, Klimek V, Camastra D, Nimer S, Pandolfi PP and Pignet SL. (2001). Blood, 98, 460a abs 1924..
12. Cameron EE, Bachman KE, Myohanen S, Herman JG and Baylin SB. (1999). Nat. Genet., 21 (1), 103-107.
13. Chen H and Wu S. (2002). Chin. Med. J., 115, 987-990.
14. Chim CS, Liang R, Tam CY and Kwong YL. (2001). J. Clin. Oncol., 19, 2033-2040.
15. Chim CS, Liang R and Kwong YL. (2002). Hematol. Oncol., 20, 167-176.
16. Claus R, Fliegauf M, Stock M, Kolanczyk M and Lübbert M. (2003). Submitted.
17. Cross SH and Bird AP. (1995). Curr. Opin. Genet. Dev., 5, 309-314.
18. Daskalakis M, Nguyen TT, Nguyen C, Guldberg P, Kohler G, Wijermans P, Jones PA and Lübbert M. (2002). Blood, 100, 2957-2964.
19. Di Croce L, Raker VA, Corsaro M, Fazi F, Fanelli M, Faretta M, Fuks F, Lo Coco F, Kouzarides T, Nervi C, Minucci S and Pelicci PG. (2002). Science, 295, 1079-1082.
20. Drexler HG. (1998). Leukemia, 12, 845-859.
21. Esteller M, Risques RA, Toyota M, Capella G, Moreno V, Peinado MA, Baylin SB and Herman JG. (2001). Cancer Res., 61, 4689-4692.
22. Esteller M. (2002). Oncogene, 21, 5427-5440.
23. Fan H, Guo X, Wu Q, Zhou T, Tan G, Wang L, Zhang X, Luo G and Xu M. (2000). Zhongguo Shi Yan Xue Ye Xue Za Zhi, 8, 271-274.
24. Garber K. (2002). J. Natl. Cancer. Inst., 94, 874-875.
25. Garcia MJ, Martinez-Delgado B, Cebrian A, Martinez A, Benitez J and Rivas C. (2002). Am. J. Pathol., 161, 1007-1013.
26. Gardiner-Garden M and Frommer M. (1987). J. Mol. Biol., 196, 261-282.
27. Gore SD, Weng LJ, Zhai S, Figg WD, Donehower RC, Dover GJ, Grever M, Griffin CA, Grochow LB, Rowinsky EK, Zabalena Y, Hawkins AL, Burks K and Miller CB. (2001). Clin. Cancer Res., 7, 2330-2339.
28. Goto T and Monk M. (1998). Microbiol. Mol. Biol. Rev., 62, 362-378.
29. Göttlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S, Sleeman JP, Lo Coco F, Nervi C, Pelicci PG and Heinzel T. (2001). EMBO J., 20, 6969-6978.
30. Graff JR, Herman JG, Myohanen S, Baylin SB and Vertino PM. (1997). J. Biol. Chem., 272, 22322-22329.
31. Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA, Minucci S and Pelicci PG. (1998). Nature, 391, 815-818.
32. Harada K, Toyooka S, Maitra A, Maruyama R, Toyooka KO, Timmons CF, Tomlinson GE, Mastrangelo D, Hay RJ, Minna JD and Gazdar AF. (2002). Oncogene, 21, 4345-4349.
33. He LZ, Tolentino T, Grayson P, Zhong S, Warrell Jr RP, Rifkind RA, Marks PA, Richon VM and Pandolfi PP. (2001). J. Clin. Invest., 108, 1321-1330.
34. Herman JG, Civin CI, Issa JP, Collector MI, Sharkis SJ and Baylin SB. (1997). Cancer Res., 57, 837-841.
35. Hoshino K, Asou N, Okubo T, Suzushima H, Kiyokawa T, Kawano F and Mitsuya H. (2002). Br. J. Haematol., 117, 531-540.
36. Issa JP, Baylin SB and Herman JG. (1997a). Leukemia, 11 (Suppl 1), S7-S11.
37. Issa JP, Zehnbauer BA, Kaufmann SH, Biel MA and Baylin SB. (1997b). Cancer Res., 57, 1678-1681.
38. Issa JP. (1999). Crit. Rev. Oncol. Hematol., 32, 31-43.
39. Issa JP, Garcia-Manero G, Mannari R, Thomas D, Giles F, Cortes J, Estey E and Kantarjian H. (2001). Blood, 98, 594a.
40. Jaenisch R and Bird A. (2003). Nat. Genet., 33 (Suppl), 245-254.
41. Jahangeer S, Elliott RM and Henneberry RC. (1982). Biochem. Biophys. Res. Commun., 108, 1434-1440.
42. Jones PA, Wolkowicz MJ, Rideout III WM, Gonzales FA, Marziasz CM, Coetzee GA and Tapscott SJ. (1990). Proc. Natl. Acad. Sci. USA, 87, 6117-6121.
43. Jones PA and Laird PW. (1999). Nat. Genet., 21, 163-167.
44. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J and Wolffe AP. (1998). Nat. Genet., 19, 187-191.
45. Jones PL and Wolffe AP. (1999). Semin. Cancer. Biol., 9, 339-347.
46. Klisovic MI, Maghraby EA, Parthun MR, Guimond M, Sklenar AR, Whitman SP, Chan KK, Murthy T, Anon J, Archer KJ, Rush LJ, Plass C, Grever MR, Byrd JC and Marcucci G. (2003). Leukemia, 17, 350-358.
47. Kouzarides T. (2002). Curr. Opin. Genet. Dev., 12, 198-209.
48. Kündgen A, Strupp C, Aivado M, Habersang K, Junge B, Hildebrandt B, Haas R, Germing U and Gattermann N. (2003). Leuk. Res., 27 (Suppl. 1), S104.
49. Leone G, Teofili L, Voso MT and Lübbert M. (2002). Haematologica, 87, 1324-1341.
50. Lin RJ, Nagy L, Inoue S, Shao W, Miller Jr WH and Evans RM. (1998). Nature, 391, 811-814.
51. Lübbert M, Brugger W, Mertelsmann R and Kanz L. (1996). Blood, 87, 447-455.
52. Lübbert M. (2000). Curr. Top. Microbiol. Immunol, 249, 135-164.
53. Lübbert M, Wijermans P, Kunzmann R, Verhoef G, Bosly A, Ravoet C, Andre M and Ferrant A. (2001). Br. J. Haematol., 114, 349-357.
54. Lübbert M, Wijermans WP, Engelhardt M and Otto F. (2002). Blood, 100 (Suppl. 1), 268b.
55. Malfoy B. (2000). J. Cell Sci., 113 (Part 22), 3887-3888.
56. Malumbres M, Perez de Castro I, Santos J, Melendez B, Mangues R, Serrano M, Pellicer A and Fernandez-Piqueras J. (1997). Oncogene, 14, 1361-1370.
57. Martinez-Delgado B, Robledo M, Arranz E, Osorio A, Garcia MJ, Echezarreta G, Rivas C and Benitez J. (1998). Leukemia, 12, 937-941.
58. Melki JR, Vincent PC and Clark SJ. (1999). Cancer Res., 59, 3730-3740.
59. Miller CB, Herman JG, Baylin SB, Galm O, Yerian JA and Gore SD. (2001). Blood, 98, 622a.
60. Mizuno S, Chijiwa T, Okamura T, Akashi K, Fukumaki Y, Niho Y and Sasaki H. (2001). Blood, 97, 1172-1179.
61. Najfeld V, Silverman LR, Scalise A and Lezon-Geyda K. (2002). Blood, 100 (Suppl.), 97a.
62. Ng MH, Chung YF, Lo KW, Wickham NW, Lee JC and Huang DP. (1997). Blood, 89, 2500-2506.
63. Nguyen C, Liang G, Nguyen TT, Tsao-Wie D, Groshen S, Lübbert M, Zhou JH, Benedict WF and Jones PA. (2001). J. Natl. Cancer. Inst., 93, 1465-1472.
64. Nguyen TT, Mohrbacher AF, Tsai YC, Groffen J, Heisterkamp N, Nichols PW, Yu MC, Lübbert M and Jones PA. (2000). Blood, 95, 2990-2992.
65. Okano M, Bell DW, Haber DA and Li E. (1999). Cell, 99, 247-257.
66. Pfeifer GP, Steigerwald S, Boehm TLJ and Drahovsky D. (1988). Cancer Lett., 39, 185-192.
67. Pinto A, Maio M, Attadia V, Zappacosta S and Cimino R. (1984). Lancet, 2, 867-868.
68. Preisler HD, Li B, Chen H, Fisher L, Nayini J, Raza A, Creech S and Venugopal P. (2001). Leukemia, 15, 1589-1595.
69. Quesnel B, Guillerm G, Verecque R, Wattel E, Preudhomme C, Bauters F, Vanrumbeke M and Fenaux P. (1998). Blood, 91, 2985-2990.
70. Richel DJ, Colly LP, Kluin-Nelemans JC and Willemze R. (1991). Br. J. Cancer, 64, 144-148.
71. Robertson KD and Wolffe AP. (2000). Nat. Rev. Genet., 1, 11-19.
72. Roman-Gomez J, Castillejo JA, Jimenez A, Gonzalez MG, Moreno F, Rodriguez Mdel C, Barrios M, Maldonado J and Torres A. (2002). Blood, 99, 2291-2296.
73. Rush LJ, Dai Z, Smiraglia DJ, Gao X, Wright FA, Fruhwald M, Costello JF, Held WA, Yu L, Krahe R, Kolitz JE, Bloomfield CD, Caligiuri MA and Plass C. (2001). Blood, 97, 3226-3233.
74. Sakashita K, Koike K, Kinoshita T, Shiohara M, Kamijo T, Taniguchi S and Kubota T. (2001). J. Clin. Invest., 108, 1195-1204.
75. Santini V, Kantarjian HM and Issa JP. (2001). Ann. Intern. Med., 134, 573-586.
76. Sato M, Horio Y, Sekido Y, Minna JD, Shimokata K and Hasegawa Y. (2002). Oncogens, 21, 4822-4829.
77. Shaker S, Bernstein M, Momparler LF and Momparler RL. (2003). Leuk. Res., 27, 437-444.
78. Shen L, Kondo Y, Issa JP and Garcia-Manero G. (2002). Blood, 100 (9), 3432-3433.
79. Sigalotti L, Altomonte M, Colizzi F, Degan M, Zagonel V, Pinto A, Gattei V and Maio M. (2003). Blood. 104; 4644-4645.
80. Silverman LR, Demakos EP, Peterson BL, Kornblith AB, Holland JC, Odchimar-Reissig R, Stone RM, Nelson D, Powell BL, DeCastro CM, Ellerton J, Larson RA, Schiffer CA and Holland JF. (2002). J. Clin. Oncol., 20, 2429-2440.
81. Singal R and Ginder GD. (1999). Blood, 93, 4059-4070.
82. Sun B, Jiang G, Zaydan MA, La Russa VF, Safah H and Ehrlich M. (2001). Cancer Res., 61, 6931-6937.
83. Teofili L, Morosetti R, Martini M, Urbano R, Putzulu R, Rutella S, Pierelli L, Leone G and Larocca LM. (2000). Exp. Hematol., 28, 519-526.
84. Teofili L, Martini M, Di Mario A, Rutella S, Urbano R, Luongo M, Leone G and Larocca LM. (2001). Blood, 98, 495-497.
85. Tien HF, Tang JH, Tsay W, Liu MC, Lee FY, Wang CH, Chen YC and Shen MC. (2001). Br. J. Haematol., 112, 148-154.
86. Toyota M, Ho C, Ohe-Toyota M, Baylin SB and Issa JP. (1999). Cancer Res., 59, 4535-4541.
87. Toyota M, Kopecky KJ, Toyata MO, Jair KW, Willman CL and Issa JP. (2001). Blood, 97, 2823-2829.
88. Uchida T, Knoshita T, Nagai H, Nakahara Y, Saito H, Hotta T and Murate T. (1997). Blood, 90, 1403-1409.
89. Wahlfors J, Hiltunen H, Heinonen E, Hämäläinen E, Alhoionen L and Jänne J. (1992). Blood, 80, 2074-2080.
90. Warrell RP Jr., He LZ, Richon V, Calleja E and Pandolfi PP. (1998). J. Natl. Cancer Inst., 90, 1621-1625.
91. Wijermans PW, Krulder JW, Huijgens PC and Neve P. (1997). Leukemia, 11, 1-5.
92. Wijermans P, Lübbert M, Verhoef G, Bosly A, Ravoet C, Andre M and Ferrant A. (2000). J. Clin. Oncol., 18, 956-962.
93. Wong IH, Ng MH, Huang DP and Lee JC. (2000). Blood, 95, 1942-1949.